Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Finding metabolites relevant to esophageal adenocarcinoma
From the Vaughan Lab, Public Health Sciences Division
Sorting out the truth about aspirin
Aspirin may cut pancreatic cancer risk, but should everyone take it?
Researchers identify four genetic variants that are linked to esophageal cancer and its precursor, Barrett’s esophagus - Fred Hutchinson Cancer Research Center
Findings from the first large-scale, genome-wide association study of esophageal adenocarcinoma may lead to new screening tools for those at high risk
Esophageal cancer risk reduced by lifestyle factors - Fred Hutchinson Cancer Research Center
April is Esophageal Cancer Awareness Month
Vaughan secures $7.9 million for esophageal cancer research
National Cancer Institute grant to evaluate genetic susceptibility for Barrett’s esophagus and esophageal adenocarcinoma
Hutchinson Center researcher secures $7.9 million NCI grant for esophageal cancer research
Study to evaluate genetic risk for Barrett’s esophagus and esophageal adenocarcinoma
Belly fat linked to Barrett's esophagus
PHS study links central body weight, precancerous condition
Farwell Award won by a 'friend'
Berta Nicol-Blades receives honor for 30 years of diligent, compassionate service to PHS Division's Epidemiologic Research Unit
Thwarting cancer's call
Barrett's esophagus team advances cutting-edge research, clinical care to curb cancer progression
Fighting cancer with NSAIDs
Regular use of aspirin and other nonsteroidal anti-inflammatory drugs may reduce esophageal-cancer risk for people with Barrett's esophagus
CARET's keys to earlier detection
PHS study finds lifetime smokers with chronic bronchitis or emphysema are at increased risk of developing lung cancer